Asha means Hope. Asha’s vision is to bring hope in the lives of patients by enhancing the bioavailability of new drugs, helping them get to the market faster and reducing drug development costs. We work with our clients through the solid form screening and selection process. Our innovative and efficient proprietary workflows help discover new solid forms (polymorphs, salts and cocrystals) of pharmaceutical molecules and enhance bioavailability of poorly soluble drugs. We aspire to be the best in class solid form research company in the world.
Discovering novel solid forms of drug molecules is an essential part of drug development and has significant regulatory, legal, financial and medical implications. This highly specialized work is frequently outsourced. Outsourcing providers need to design scientifically rigorous and efficient experiments to generate quality data and reduce time and labor requirements. They also need to help clients select the optimal solid form. Scalability of the forms and processes discovered at this stage is a key aspect which is often overlooked. Smaller pharma companies with limited resources often skip this critical task or can only afford substandard data which leads to significant costs further downstream in development or leads to promising drug molecules not making it to market.
Asha’s innovative and efficient workflows have been built using the latest advances in solid form science and are easily customizable based on the drug molecule and the drug development timeline (Phase-Appropriate). We understand that our clients are often dealing with short timelines and we use a risk based approach to discover and select polymorphs, salts and cocrystals. We are experts in finding the optimal solution to a solid form problem taking into account the time and resources available. Our Chemical Engineering expertise helps us keep scalability of our solid forms and processes in mind even at the screening stage.
A particular focus is generating high quality scientific data for smaller companies at a reasonable cost and enhancing the bioavailability of poorly soluble molecules.